126 related articles for article (PubMed ID: 23958603)
1. NAFLD: Profiling NAFLD--liver gene expression and DNA methylation patterns to characterize disease severity.
Ray K
Nat Rev Gastroenterol Hepatol; 2013 Oct; 10(10):565. PubMed ID: 23958603
[No Abstract] [Full Text] [Related]
2. Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease.
Murphy SK; Yang H; Moylan CA; Pang H; Dellinger A; Abdelmalek MF; Garrett ME; Ashley-Koch A; Suzuki A; Tillmann HL; Hauser MA; Diehl AM
Gastroenterology; 2013 Nov; 145(5):1076-87. PubMed ID: 23916847
[TBL] [Abstract][Full Text] [Related]
3. Normalization of a NAFLD gene expression signature.
Vinciguerra M
Hepatology; 2014 Oct; 60(4):1445. PubMed ID: 24493162
[No Abstract] [Full Text] [Related]
4. Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease.
Moylan CA; Pang H; Dellinger A; Suzuki A; Garrett ME; Guy CD; Murphy SK; Ashley-Koch AE; Choi SS; Michelotti GA; Hampton DD; Chen Y; Tillmann HL; Hauser MA; Abdelmalek MF; Diehl AM
Hepatology; 2014 Feb; 59(2):471-82. PubMed ID: 23913408
[TBL] [Abstract][Full Text] [Related]
5. Reply: To PMID 23913408.
Moylan CA; Pang H; Michelotti G; Diehl AM
Hepatology; 2014 Oct; 60(4):1445-6. PubMed ID: 24493022
[No Abstract] [Full Text] [Related]
6. Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease.
Pirola CJ; Gianotti TF; Burgueño AL; Rey-Funes M; Loidl CF; Mallardi P; Martino JS; Castaño GO; Sookoian S
Gut; 2013 Sep; 62(9):1356-63. PubMed ID: 22879518
[TBL] [Abstract][Full Text] [Related]
7. Association of Hepatic Global DNA Methylation and Serum One-Carbon Metabolites with Histological Severity in Patients with NAFLD.
Lai Z; Chen J; Ding C; Wong K; Chen X; Pu L; Huang Q; Chen X; Cheng Z; Liu Y; Tan X; Zhu H; Wang L
Obesity (Silver Spring); 2020 Jan; 28(1):197-205. PubMed ID: 31785086
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery.
Ahrens M; Ammerpohl O; von Schönfels W; Kolarova J; Bens S; Itzel T; Teufel A; Herrmann A; Brosch M; Hinrichsen H; Erhart W; Egberts J; Sipos B; Schreiber S; Häsler R; Stickel F; Becker T; Krawczak M; Röcken C; Siebert R; Schafmayer C; Hampe J
Cell Metab; 2013 Aug; 18(2):296-302. PubMed ID: 23931760
[TBL] [Abstract][Full Text] [Related]
9. The genetics of NAFLD.
Anstee QM; Day CP
Nat Rev Gastroenterol Hepatol; 2013 Nov; 10(11):645-55. PubMed ID: 24061205
[TBL] [Abstract][Full Text] [Related]
10. Is nonalcoholic fatty liver disease in children the same disease as in adults?
Hsu E; Murray K
Clin Liver Dis; 2012 Aug; 16(3):587-98. PubMed ID: 22824482
[TBL] [Abstract][Full Text] [Related]
11. Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver.
Yamada H; Suzuki K; Ichino N; Ando Y; Sawada A; Osakabe K; Sugimoto K; Ohashi K; Teradaira R; Inoue T; Hamajima N; Hashimoto S
Clin Chim Acta; 2013 Sep; 424():99-103. PubMed ID: 23727030
[TBL] [Abstract][Full Text] [Related]
12. Histopathology of nonalcoholic fatty liver disease.
Brunt EM; Tiniakos DG
World J Gastroenterol; 2010 Nov; 16(42):5286-96. PubMed ID: 21072891
[TBL] [Abstract][Full Text] [Related]
13. Serum metabolomic profile and potential biomarkers for severity of fibrosis in nonalcoholic fatty liver disease.
Tokushige K; Hashimoto E; Kodama K; Tobari M; Matsushita N; Kogiso T; Taniai M; Torii N; Shiratori K; Nishizaki Y; Ohga T; Ohashi Y; Sato T
J Gastroenterol; 2013 Dec; 48(12):1392-400. PubMed ID: 23478936
[TBL] [Abstract][Full Text] [Related]
14. Influence of adiponectin gene polymorphisms in Japanese patients with non-alcoholic fatty liver disease.
Tokushige K; Hashimoto E; Noto H; Yatsuji S; Taniai M; Torii N; Shiratori K
J Gastroenterol; 2009; 44(9):976-82. PubMed ID: 19484180
[TBL] [Abstract][Full Text] [Related]
15. Genetic and epigenetic variants influencing the development of nonalcoholic fatty liver disease.
Li YY
World J Gastroenterol; 2012 Dec; 18(45):6546-51. PubMed ID: 23236228
[TBL] [Abstract][Full Text] [Related]
16. Nonalcoholic fatty liver disease (NAFLD)--two decades later: are we smarter about its natural history?
Ong JP; Younossi ZM
Am J Gastroenterol; 2003 Sep; 98(9):1915-7. PubMed ID: 14499766
[No Abstract] [Full Text] [Related]
17. Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment.
Dongiovanni P; Anstee QM; Valenti L
Curr Pharm Des; 2013; 19(29):5219-38. PubMed ID: 23394097
[TBL] [Abstract][Full Text] [Related]
18. The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease.
Rotman Y; Koh C; Zmuda JM; Kleiner DE; Liang TJ;
Hepatology; 2010 Sep; 52(3):894-903. PubMed ID: 20684021
[TBL] [Abstract][Full Text] [Related]
19. Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis.
Bechmann LP; Kocabayoglu P; Sowa JP; Sydor S; Best J; Schlattjan M; Beilfuss A; Schmitt J; Hannivoort RA; Kilicarslan A; Rust C; Berr F; Tschopp O; Gerken G; Friedman SL; Geier A; Canbay A
Hepatology; 2013 Apr; 57(4):1394-406. PubMed ID: 23299969
[TBL] [Abstract][Full Text] [Related]
20. Levels of serum ceruloplasmin associate with pediatric nonalcoholic fatty liver disease.
Nobili V; Siotto M; Bedogni G; Ravà L; Pietrobattista A; Panera N; Alisi A; Squitti R
J Pediatr Gastroenterol Nutr; 2013 Apr; 56(4):370-5. PubMed ID: 23154483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
